2023
Levodopa for Dystonia in Children: A Case Series and Review of the Literature
DeArias A, Bamford N. Levodopa for Dystonia in Children: A Case Series and Review of the Literature. Pediatric Neurology 2023, 152: 16-19. PMID: 38176223, DOI: 10.1016/j.pediatrneurol.2023.12.012.Peer-Reviewed Original ResearchMotor functionMarsden Dystonia Rating ScaleLimited effective treatment optionsDystonia Rating ScaleEffective treatment optionForms of dystoniaLong-term treatmentShort-term useDopa-responsive dystoniaCarbidopa-levodopaBurke-FahnRetrospective reviewCase seriesHyperkinetic movementsTreatment optionsUntoward effectsExamination notesDystoniaSignificant causeLevodopaRating ScaleTrial periodChildrenTreatmentReview
2019
Localising movement disorders in childhood
Bamford NS, McVicar K. Localising movement disorders in childhood. The Lancet Child & Adolescent Health 2019, 3: 917-928. PMID: 31653548, PMCID: PMC7102738, DOI: 10.1016/s2352-4642(19)30330-x.Peer-Reviewed Original ResearchConceptsMovement disordersBasal gangliaBasal ganglia functionMajor movement disordersGanglia functionNew pharmacologicalTreatment decisionsClinical definitionSynaptic functionElectrophysiological approachesDisordersMotor learningGangliaChildrenIon channelsThalamusCortexPharmacologicalDiseasePhysiological frameworkDiagnosisNeuronsReceptors
2009
Neuromuscular hip dysplasia in Charcot–Marie–Tooth disease type 1A
BAMFORD NS, WHITE KK, ROBINETT SA, OTTO RK, GOSPE SM. Neuromuscular hip dysplasia in Charcot–Marie–Tooth disease type 1A. Developmental Medicine & Child Neurology 2009, 51: 408-411. PMID: 19388151, DOI: 10.1111/j.1469-8749.2008.03234.x.Peer-Reviewed Original ResearchConceptsNeuromuscular hip dysplasiaHip dysplasiaClinical signsCharcot-MarieType 1AInconsistent clinical signsInitial clinical signsTooth disease type 1ACMT type 1APeripheral neuropathyHip diseaseOrthopedic abnormalitiesTooth diseaseNeurological disordersCMT 1A.DysplasiaFrequent formDiseaseSignsChildrenConsiderable variabilityNeuropathySymptomsAbnormalitiesDiagnosis